News

Oligonucleotide Therapeutics: How siRNA and ASO Are Expanding Beyond the Liver

Oligonucleotide therapeutics are expanding beyond rare diseases and liver-targeted delivery. Explore how advances in siRNA, ASOs, extrahepatic delivery, and multi-target strategies are opening new possibilities across major disease areas.